Very sad to hear of Darcy Doherty’s death yesterday. Following article notes how his death, and the campaign his family led, for compassionate access to last chance drugs. Quote:
Mr. Doherty’s public campaign sparked an ethical debate. Should patients, especially those with little hope, have compassionate access to drugs outside of clinical trials when other options have been exhausted? Or is it too risky to give unfettered access to drugs not yet approved by Health Canada that could cause adverse events, including death?
My thoughts go out to Darcy’s family and friends. I am sure that their support and campaign, in addition to raising this issue on his behalf and that of other patients in similar circumstances, must have helped Darcy in his last months through the support and love it showed for him, even if he ran out of time.
Cancer patient’s death strengthens a push for last-chance drugs – The Globe and Mail.
